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Introduction. We began to use hypofractionated radiotherapy schedule in combination with image guided radiation therapy (IGRT)
on localized prostate cancer on June of 2012. Daily on-line veriﬁcation is required when using IGRT to treat the prostate gland,
especially when using it to increase the precision and accuracy in radiation delivery on hypofractionated schedules. Daily pre-
treatment localization of the prostate gland was performed with Cone Beam CT (CBCT), which allows to locate the PTV under
the linear accelerator just before the irradiation, by direct visualization (3D mode soft tissue).
Objective. To measure timing from CBCT start to radiotherapy delivery on a daily basis.
Method. A descriptive, observational, quantitative cross method. Sample: 500 CBCT pre-treatment on 25 patients. Total dose
60Gy in 20 daily fractions of 3Gy. Lineal accelerator (LINAC) Sinergy Elekta. Beam Energy: 15MV. Data gathered from June 2012 to
January 2013. Analysis of data using frequency measures and measures of central tendency. Conﬁdence level: 95%. Excel Program.
Results. Preliminary data. Average patient positioning and CBCT timing: 7min and 20 s Average treatment timing: 6min and 10 s
Average total fraction timing: 13min and 30 s.
Conclusion. Because of there are no references in the related bibliography, we suggest to carry on further studies in order to set a
reference baseline. Despite the increased time it takes to perform a daily CBCT, we consider this absolutely necessary given the
beneﬁt shown on the hypofractionated schedule: LINAC usage optimization, increases safety and patient comfort.
http://dx.doi.org/10.1016/j.rpor.2013.03.620
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Introduction. The complexity of current IMRT cranial radiosurgery treatments requires that the calculations performed with the
planning system must be veriﬁed with experimental data from Novalis Brainlab Linac.
Objectives. Assess the geometric and dosimetric viability of a treatment plan. Experimentally verify the agreement between the
imparted dose by the linac and the calculated dose by the planning system.
Materials and methods. Novalis Brainlab accelerator. IMRT (Iba Dosimetry) with ﬁlm allocation. −15 cm×15 cm EBT2 Radiocromic
ﬁlm. Lucy 3D QA Phantom (Standard Image) Pinpoint 3D Chamber (PTW Freiburg) with electrometer. Omnipro Software.
Two methods are employed: Phantom dose distribution veriﬁcation. The IMRT Iba Dosimetry phantom is loaded with EBT2
Radiochromic ﬁlm. The phantom center is aligned with the laser reticule in such a way that the radiochromic ﬁlm is placed in a
coronal plane that contains the isocenter. Image processing and analysis is done within Omnipro Software. Absorbed dose at a
speciﬁc point veriﬁcation. The Lucy 3D QA Phantom is loaded with the Pinpoint 3D Chamber. The phantom center is aligned with
the laser reticule in such a way that the chamber center point matches the isocenter. In both cases the phantoms are irradiated
with the patient’s treatment ﬁelds.
Results. The gamma index-based analysis performed on relative dosimetry results shows a good agreement between the EBT2 ﬁlm
dose distribution and the planning system’s calculated dose plane. The absorbed dose dosimetry results also show a good match
between measurements and the planning system calculated dose. A ﬁeld-by-ﬁeld match is performed for the chamber-measured
point dose and a total ﬁeld sum match is done in the case of the radiochromic ﬁlm.
Conclusions. These two methods provide a reliable, effective solution for veriﬁcation of treatment plan calculations. Both methods
are also fast and easy to implement, and complement each other.
http://dx.doi.org/10.1016/j.rpor.2013.03.621
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Introduction. IMRT is a special technique which administers high doses to tumors while avoiding overdosing of organs at risk.
Objective. Detailed description of the steps in the simulation of a IMRT prostate.
Methodology. Own experience with IM and Set up margin during treatment; International and National guidelines and consensus
medical Technical/Physics Following protocol CIRCUIT: First visit, Endorectal ultrasound: gold markers, RMN (volumetric),
ct-simulation (7-10 days after gold markers placement), Planning, Assessment and plan approval, Quality control
physic/dosimetric (DRR from CT images: AP and lateral), Treatment: Clinical Quality Assurance. ct SIMULATION: Fasting
for 6h before, Cleaning Enema TC previous night and morning, Attend one hour before appointment of patient to drink oral
contrast (500ml), Full bladder and rectum empty, Contrast IV, Supine, Triangle in legs, Acquisition: Protocol (pelvis) from L4
to below the minor trochanter. Prostate and vesicles each 2mm, 5mm each remaining pelvis, Tattoos: 3 iso and 1 sagittal
